Business Description
Inter Pharma PCL
ISIN : TH9474010005
Description
Inter Pharma PCL is a biopharmaceutical company. It is engaged in the import, manufacture and distribution of drug, and dietary supplement products for humans and animals. It offers products related to Wellness and Anti-aging, Aesthetics, Diagnostics, Vitamins, and other products. The company operates in three reportable segments Human healthcare, Animal Healthcare, and Hospital in Thailand. Key revenue is derived from the Human healthcare segment.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.03 | |||||
| Equity-to-Asset | 0.65 | |||||
| Debt-to-Equity | 0.21 | |||||
| Debt-to-EBITDA | 1.95 | |||||
| Interest Coverage | 4.25 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 2.7 | |||||
| Beneish M-Score | -2.36 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 46.3 | |||||
| 3-Year EBITDA Growth Rate | 24.7 | |||||
| 3-Year EPS without NRI Growth Rate | -9.1 | |||||
| 3-Year FCF Growth Rate | 9.5 | |||||
| 3-Year Book Growth Rate | 46.9 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 2.96 | |||||
| 9-Day RSI | 7.02 | |||||
| 14-Day RSI | 11.91 | |||||
| 6-1 Month Momentum % | 3.65 | |||||
| 12-1 Month Momentum % | -12.72 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.51 | |||||
| Quick Ratio | 1.79 | |||||
| Cash Ratio | 0.86 | |||||
| Days Inventory | 115.62 | |||||
| Days Sales Outstanding | 64.21 | |||||
| Days Payable | 61.46 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.88 | |||||
| Dividend Payout Ratio | 1.52 | |||||
| 3-Year Dividend Growth Rate | 11.1 | |||||
| Forward Dividend Yield % | 0.59 | |||||
| 5-Year Yield-on-Cost % | 1.82 | |||||
| 3-Year Average Share Buyback Ratio | -8.7 | |||||
| Shareholder Yield % | 4.83 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 37.02 | |||||
| Operating Margin % | 6.14 | |||||
| Net Margin % | 2.85 | |||||
| FCF Margin % | -1.27 | |||||
| ROE % | 2.63 | |||||
| ROA % | 1.7 | |||||
| ROIC % | 3.84 | |||||
| ROC (Joel Greenblatt) % | 8.82 | |||||
| ROCE % | 4.26 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 80.93 | |||||
| PE Ratio without NRI | 80.93 | |||||
| Price-to-Owner-Earnings | 369.23 | |||||
| PEG Ratio | 2.98 | |||||
| PS Ratio | 2.01 | |||||
| PB Ratio | 1.15 | |||||
| Price-to-Tangible-Book | 1.78 | |||||
| Price-to-Operating-Cash-Flow | 29.39 | |||||
| EV-to-EBIT | 20.42 | |||||
| EV-to-EBITDA | 10.65 | |||||
| EV-to-Revenue | 1.23 | |||||
| EV-to-FCF | -96.47 | |||||
| Price-to-Peter-Lynch-Fair-Value | 3.23 | |||||
| Price-to-Graham-Number | 2.52 | |||||
| Price-to-Net-Current-Asset-Value | 13.43 | |||||
| Earnings Yield (Greenblatt) % | 4.9 | |||||
| FCF Yield % | -1.03 | |||||
| Forward Rate of Return (Yacktman) % | 18.45 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Inter Pharma PCL Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ฿) | 1,781.234 | ||
| EPS (TTM) (฿) | 0.073 | ||
| Beta | 0.81 | ||
| Volatility % | 30.72 | ||
| 14-Day RSI | 11.91 | ||
| 14-Day ATR (฿) | 0.482901 | ||
| 20-Day SMA (฿) | 9.652885 | ||
| 12-1 Month Momentum % | -12.72 | ||
| 52-Week Range (฿) | 4.8 - 8.307692 | ||
| Shares Outstanding (Mil) | 372.52 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Inter Pharma PCL Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Inter Pharma PCL Stock Events
| Event | Date | Price(฿) | ||
|---|---|---|---|---|
| No Event Data | ||||
Inter Pharma PCL Frequently Asked Questions
What is Inter Pharma PCL(BKK:IP)'s stock price today?
The current price of BKK:IP is ฿5.91. The 52 week high of BKK:IP is ฿8.31 and 52 week low is ฿4.80.
When is next earnings date of Inter Pharma PCL(BKK:IP)?
The next earnings date of Inter Pharma PCL(BKK:IP) is .
Does Inter Pharma PCL(BKK:IP) pay dividends? If so, how much?
The Dividend Yield %  of Inter Pharma PCL(BKK:IP) is 1.88% (As of Today), Highest Dividend Payout Ratio of Inter Pharma PCL(BKK:IP) was 1.52. The lowest was 0.06. And the median was 0.72. The  Forward Dividend Yield % of Inter Pharma PCL(BKK:IP) is 0.59%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers